AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Go back to AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024| Amgen Inc (NASDAQ: AMGN) | Delayed: 429.88 -2.54 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $432.42 | 52 Week High | $176.85 | |||
| Open | $428.59 | 52 Week Low | $133.64 | |||
| Day High | $431.85 | P/E | 64.74 | |||
| Day Low | $426.00 | EPS | $6.64 | |||
| Volume | 2,354,736 | |||||

